Comparison with Ezh2 reveals the PRC2-dependent functions of Jarid2 in hematopoietic stem Cell lineage commitment
Stem Cell Reports · 2026
DOI: 10.1016/j.stemcr.2026.102793 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Stem Cell Reports, 2026. Verfasst von Hassan Bjeije und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA. Hauptthemen laut MEDLINE: Polycomb Repressive Complex 2, Enhancer of Zeste Homolog 2 Protein, Hematopoietic Stem Cells, Cell Lineage. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Heart Lung and Blood Institute, Washington University in St. Louis, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Previous studies showed the polycomb repressive complex 2 (PRC2) co-factor Jarid2 represses self-renewal transcriptional networks in mouse multipotent progenitor cells (MPPs). But only a fraction of de-repressed HSC-specific genes were associated with loss of H3K27me3, implying Jarid2 may have non-canonical (PRC2-independent) functions in hematopoiesis. We sought to delineate these potential PRC2-independent functions by comparing stem and progenitor cells genetically deficient for either Jarid2 or Ezh2 (enzymatic component of PRC2). Loss of Ezh2 increased myeloid differentiation but with a defect in lymphopoiesis. In contrast, loss of Jarid2 enhanced multi-lineage differentiation proportionally. Single-cell transcriptomics showed loss of Jarid2 had minimal impact across progenitor populations, but loss of Ezh2 led to accumulation of lymphoid-biased MPP4 cells and B cell progenitors in the bone marrow. Functional assays confirmed a differentiation block at the pre-pro-B cell stage. These data suggest the major PRC2-dependent function of Jarid2 in hematopoietic progenitors is restriction of myeloid differentiation potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
- Division of Hematology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
- Department of Pediatrics, Washington University School of Medicine, St. Louis, MO 63110, USA.
- Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA. Electronic address: grantchallen@wustl.edu.
Förderung
- National Heart Lung and Blood Institute
- Washington University in St. Louis
- National Institute of Diabetes and Digestive and Kidney Diseases
- American Cancer Society Inc
- Leukemia and Lymphoma Society
- National Institutes of Health National Cancer Institute
- St. Louis Children's Hospital
- Edward P. Evans Foundation
Zitieren
APA
Bjeije, H., Han, W., Lin, S., Issa, N., Krishnan, A., Raj, I. X., Arand, J., Li, Y., Yang, W., Magee, J. A., & Challen, G. A. (2026). Comparison with Ezh2 reveals the PRC2-dependent functions of Jarid2 in hematopoietic stem Cell lineage commitment. Stem Cell Reports. https://doi.org/10.1016/j.stemcr.2026.102793
Vancouver
Bjeije H, Han W, Lin S, Issa N, Krishnan A, Raj IX, et al. Comparison with Ezh2 reveals the PRC2-dependent functions of Jarid2 in hematopoietic stem Cell lineage commitment. Stem Cell Reports. 2026. doi:10.1016/j.stemcr.2026.102793
BibTeX
@article{Bjeije2026,
author = {Bjeije, Hassan and Han, Wentao and Lin, Shuyang and Issa, Nancy and Krishnan, Aishwarya and Raj, Infencia Xavier and Arand, Jason and Li, Yanan and Yang, Wei and Magee, Jeffrey A and Challen, Grant A},
title = {Comparison with Ezh2 reveals the PRC2-dependent functions of Jarid2 in hematopoietic stem Cell lineage commitment},
journal = {Stem Cell Reports},
year = {2026},
doi = {10.1016/j.stemcr.2026.102793}
}
EUVIMED